| 000 | 01135 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515161126.0 | ||
| 264 | 0 | _c20100215 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1095-9130 | ||
| 024 | 7 |
_a10.1016/j.ymeth.2009.02.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Min | |
| 245 | 0 | 0 |
_aNucleoprotein complex intermediates in HIV-1 integration. _h[electronic resource] |
| 260 |
_bMethods (San Diego, Calif.) _cApr 2009 |
||
| 300 |
_a237-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 |
_aDNA, Viral _xmetabolism |
| 650 | 0 | 4 | _aGenetic Techniques |
| 650 | 0 | 4 |
_aHIV Integrase _xmetabolism |
| 650 | 0 | 4 |
_aHIV Integrase Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aHIV-1 _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNucleoproteins _xmetabolism |
| 650 | 0 | 4 |
_aSubstrate Specificity _xphysiology |
| 650 | 0 | 4 |
_aVirus Integration _xphysiology |
| 700 | 1 | _aCraigie, Robert | |
| 773 | 0 |
_tMethods (San Diego, Calif.) _gvol. 47 _gno. 4 _gp. 237-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ymeth.2009.02.001 _zAvailable from publisher's website |
| 999 |
_c18674955 _d18674955 |
||